<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>非住院患者6个月后发现对SARS-CoV2的细胞免疫</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">非住院患者6个月后发现对SARS-CoV2的细胞免疫</h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2020-11-02 22:12:28</div><div class="page_narrow text-break page_content"><p>Cellular (T cell) immunity against SARS-CoV-2 is likely to be present within most adults six months after primary infection, a new pre-print on bioRxiv suggests. The research from the UK Coronavirus Immunology Consortium (UK-CIC), Public Health England and Manchester University NHS Foundation Trust demonstrates robust T cell responses to SARS-CoV-2 virus peptides at this timepoint in all participants following asymptomatic or mild/moderate COVID-19 infection.</p><p>BioRxiv上的一份新的预印本表明，对SARS-CoV-2的细胞(T细胞)免疫很可能在初次感染后6个月的大多数成年人中出现。来自英国冠状病毒免疫联盟、英国公共卫生和曼彻斯特大学国民保健服务基金会信托基金的这项研究表明，在新冠肺炎无症状或轻/中度感染后，所有参与者在这个时间点都对SARS-CoV-2病毒肽产生了强大的T细胞反应。</p><p> A key question is whether previous infection with SARS-CoV-2 results in immunity to reinfection, and if so for how long. The immune system is extremely complex and there are many different potential routes whereby it can generate immunity to a disease post-infection. This study examines the role of T cells in contributing to immunity against SARS-CoV-2 at six months post infection.</p><p>一个关键问题是，以前感染SARS-CoV-2是否会导致对再次感染的免疫力，如果是的话，会持续多久。免疫系统极其复杂，有许多不同的潜在途径可使其在感染后产生对疾病的免疫力。这项研究检测了T细胞在感染后6个月对SARS-CoV-2免疫的作用。</p><p> As part of UK-CIC, researchers from the University of Birmingham, Public Health England, Manchester University NHS Foundation Trust (MFT) and NIHR Manchester Clinical Research Facility collected serum and blood samples from a cohort of more than 2,000 clinical and non-clinical healthcare workers including 100 individuals who tested sero-positive for SARS-CoV-2 in March/April 2020 (average age 41 (range 22–65); 23 men, 77 women). All 100 individuals experienced either mild/moderate symptoms or were asymptomatic (56 versus 44 people) and none were hospitalised for COVID-19. Serum samples were collected monthly to measure antibody levels, and blood samples were taken after six months to assess the cellular (T cell) response. A range of analyses were carried out to assess different aspects of the T cell response including the magnitude of response and the response to different proteins from SARS-CoV-2. Carrying out these cellular analyses is much more complex than antibody studies – but this study of 100 individuals is one of the largest in the world to date in this field.</p><p>作为UK-CIC的一部分，来自英国伯明翰大学公共卫生分校、曼彻斯特大学NHS基金会信托基金(MFT)和NIHR曼彻斯特临床研究设施的研究人员从2000多名临床和非临床医护人员的队列中收集了血清和血液样本，其中包括100名在2020年3月/4月检测出SARS-CoV-2血清阳性的个人(平均年龄41岁(范围22-65岁；23名男性，77名女性)。所有100名患者都出现了轻度/中度症状或无症状(56人对44人)，没有人因新冠肺炎住院。每月采集血清样本以测量抗体水平，并在6个月后采集血液样本以评估细胞(T细胞)反应。进行了一系列分析以评估T细胞反应的不同方面，包括反应的大小和对SARS-CoV-2不同蛋白的反应。进行这些细胞分析比抗体研究复杂得多，但这项针对100人的研究是该领域迄今为止世界上规模最大的研究之一。</p><p> T cell responses were present in all individuals at six months after SARS-CoV-2 infection. The cellular immune response was directed against a range of proteins from the virus, including the Spike protein that is being used in most vaccine studies. However, comparable immunity was present against additional proteins, such as nucleoprotein, which suggests that these may be of value for incorporation in future vaccine protocols. This indicates that a robust cellular memory against the virus persists for at least six months.</p><p>在SARS-CoV-2感染后6个月，所有个体都有T细胞应答。细胞免疫反应针对病毒的一系列蛋白，包括大多数疫苗研究中使用的Spike蛋白。然而，对核蛋白等额外蛋白也存在类似的免疫力，这表明这些蛋白可能对未来的疫苗方案有价值。这表明，对病毒的强大细胞记忆至少可以持续六个月。</p><p> The size of T cell response differed between individuals, being considerably (50%) higher in people who had experienced symptomatic disease at the time of infection six months previously. Further research will be needed to determine the significance of this finding. It is possible that heightened cellular immunity might provide increased protection against re-infection in people with initial symptomatic infection, or that asymptomatic individuals are simply able to fight off the virus without the need to generate a large immune response.</p><p>T细胞反应的大小因个体不同而不同，在6个月前感染时经历过症状性疾病的人中，T细胞反应的大小要高得多(50%)。还需要进一步的研究来确定这一发现的意义。提高细胞免疫力可能会增强最初有症状感染的人对再次感染的保护，或者没有症状的人可以简单地击退病毒，而不需要产生大量的免疫反应，这可能是因为细胞免疫增强可能会增强对再次感染的保护作用，或者没有症状的人可以简单地击退病毒，而不需要产生大量的免疫反应。</p><p> Antibodies are also a crucial component of immune defence and cellular immunity was strongly correlated with the peak level of the antibody response. Furthermore, larger cellular responses appeared to protect against antibody ‘waning’ over time, again suggesting the need to ensure that cellular immune responses are elicited in vaccine regimens.</p><p>抗体也是免疫防御的重要组成部分，细胞免疫与抗体应答峰值密切相关。此外，随着时间的推移，更大的细胞反应似乎可以防止抗体“减弱”，这再次表明有必要确保在疫苗方案中激发细胞免疫反应。</p><p> Overall, these findings indicate a robust cellular (T cell) immune response against SARS-CoV-2 at six months post-infection. These findings will feed not only into our understanding of how immunity to SARS-CoV-2 works but also help inform future vaccine strategies. Further research is now needed to assess whether this immune response is maintained over the longer term and to better understand how strength of cellular immune response corresponds to likelihood of reinfection.</p><p>总体而言，这些发现表明，在感染后6个月，针对SARS-CoV-2的细胞(T细胞)免疫反应很强。这些发现不仅将有助于我们理解对SARS-CoV-2的免疫是如何起作用的，而且也有助于为未来的疫苗策略提供信息。现在需要进一步的研究来评估这种免疫反应是否能长期维持，并更好地了解细胞免疫反应的强度如何与再感染的可能性相对应。</p><p>   “Understanding what constitutes effective immunity to SARS-CoV-2 is extremely important, both to allow us to understand how susceptible individuals are to reinfection and to help us develop more effective COVID-19 vaccines.</p><p>了解是什么构成了对SARS-CoV-2的有效免疫力是极其重要的，这既可以让我们了解个人对再次感染的易感性有多大，也可以帮助我们开发更有效的新冠肺炎疫苗。</p><p> “To our knowledge, our study is the first in the world to show robust cellular immunity remains at six months after infection in individuals who experienced either mild/moderate or asymptomatic COVID-19. Interestingly, we found that cellular immunity is stronger at this time point in those people who had symptomatic infection compared with asymptomatic cases. We now need more research to find out if symptomatic individuals are better protected against reinfection in the future.</p><p>据我们所知，我们的研究是世界上第一个显示经历过轻度/中度或无症状新冠肺炎的人在感染后6个月仍保持强大细胞免疫力的研究。有趣的是，我们发现在这个时间点，与没有症状的病例相比，有症状感染的人的细胞免疫力更强。我们现在需要更多的研究来找出是否对有症状的个人在未来再次感染有更好的保护。</p><p> “Our knowledge of SARS-CoV-2 infection is increasing all the time. While our findings cause us to be cautiously optimistic about the strength and length of immunity generated after SARS-CoV-2 infection, this is just one piece of the puzzle. There is still a lot for us learn before we have a full understanding of how immunity to COVID-19 works. While we increase our understanding, whether we think we have previously had COVID-19 or not, we all should still follow Government guidelines on social distancing to ensure we play our part in minimising the spread of COVID-19 within our communities.”</p><p>他说：“我们对SARS-CoV-2感染的认识一直在增加。虽然我们的发现使我们对SARS-CoV-2感染后产生的免疫力的强度和持续时间持谨慎乐观态度，但这只是拼图的一部分。在我们完全了解新冠肺炎的免疫力是如何起作用之前，我们还有很多需要学习的地方。当我们加深了解的同时，无论我们认为以前有没有新冠肺炎，我们都应该遵守政府有关社交距离的指引，以确保我们在尽量减少新冠肺炎在社区内的传播方面发挥自己的作用。“。</p><p>  Dr Shamez Ladhani, Consultant epidemiologist at Public Health England and the study’s author, said:</p><p>这项研究的作者、英国公共卫生的流行病学家沙梅兹·拉德哈尼博士说：</p><p> “Cellular immunity is a complex but potentially very significant piece of the COVID-19 puzzle, and it’s important that more research be done in this area. However, early results show that T-cell responses may outlast the initial antibody response, which could have a significant impact on COVID vaccine development and immunity research.</p><p>“细胞免疫是新冠肺炎之谜中复杂但可能非常重要的一块，重要的是在这一领域做更多的研究。然而，早期的研究结果表明，T细胞的反应可能比最初的抗体反应持续时间更长，这可能会对COVID疫苗的开发和免疫研究产生重大影响。</p><p> “Our thanks go to the more than 2,000 staff who have volunteered to provide monthly blood samples since the beginning of the pandemic. Recruiting donors so early in 2020 allowed us significantly longer follow-up than many similar studies have achieved so far.”</p><p>“我们要感谢自大流行开始以来自愿每月提供血样的2000多名工作人员。我们在2020年初就招募捐赠者，这让我们获得了比迄今为止许多类似研究都要长得多的随访时间。“。</p><p>  “This study shows the benefit of funding world-leading immunologists through the UK Coronavirus Immunology Consortium. Researchers investigated whether previous infection with SARS-CoV-2 results in immunity to reinfection. They found that a robust cellular memory against the virus persists for at least six months. This is promising news – if natural infection with the virus can elicit a robust T cell response then this may mean that a vaccine could do the same.”</p><p>这项研究显示了通过英国冠状病毒免疫联盟资助世界领先的免疫学家的好处。研究人员调查了以前感染SARS-CoV-2是否会导致对再次感染的免疫力。他们发现，对抗病毒的强大细胞记忆至少可以持续六个月。这是一个很有希望的消息--如果自然感染病毒可以引发强大的T细胞反应，那么这可能意味着疫苗也可以起到同样的作用。“。</p><p>  Dr Shazaad Ahmad, Consultant Virologist at Manchester University NHS Foundation Trust (MFT) and Principal Investigator for the study at MFT, said:</p><p>曼彻斯特大学NHS基金会信托基金(MFT)的顾问病毒学家、MFT这项研究的首席研究员沙扎德·艾哈迈德博士说：</p><p> “As one of the leading NHS trusts for research and innovation, known for our strong track record of recruiting to studies, we were selected to rapidly enlist a cohort of healthcare workers to take part in this important research – and 1,200 MFT staff swiftly answered the call.</p><p>作为NHS领先的研究和创新信托机构之一，我们以招募研究人员的良好记录而闻名，我们被选中迅速招募一批医疗工作者参与这项重要的研究-MFT的1200名工作人员迅速响应了这一号召。</p><p> “The study was delivered at the NIHR Manchester Clinical Research Facilities at Manchester Royal Infirmary and Wythenshawe Hospital (both part of MFT), which provide dedicated research space and highly-trained staff. I would like to say how grateful I am to my colleagues for continuing to deliver and participate in this study, as without them we would not be able to report the findings, which could have a huge global impact.&#34;</p><p>这项研究是在曼彻斯特皇家医院和Wythenshawe医院(都是MFT的一部分)的NIHR曼彻斯特临床研究设施进行的，这两个医院提供专门的研究空间和训练有素的工作人员。我想说，我非常感谢我的同事们继续提供和参与这项研究，因为如果没有他们，我们就不能报告这些发现，这可能会产生巨大的全球影响。</p><p> Please note, this paper is a pre-print reporting preliminary data that has not yet been peer-reviewed.</p><p>请注意，本论文是一份印刷前报告，初步数据尚未经过同行评审。</p><p>  Notes for editors This press release reports on findings in the following pre-print which is currently being uploaded to bioRxiv: Zuo  et al. 2020 Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection Journalists - please contact the press team for a copy of the preprint.</p><p>编辑注意：本新闻稿报道了以下预印本中的发现，该预印本目前正在上传到BioRxiv：Zuo等人。2020年强大的SARS-CoV-2特异性T细胞免疫力在初次感染后6个月保持不变-请联系新闻组索取预印本。</p><p> The UK Coronavirus Immunology Consortium brings together UK 19 immunology centres of excellence to research how the immune system interacts with SARS-CoV-2 to help us improve patient care and develop better diagnostics, treatments and vaccines against COVID-19. It is jointly funded by UK Research and Innovation (UKRI) and National Institute for Health Research (NIHR) and supported by the British Society for Immunology. Website:  www.uk-cic.org  Twitter:  @UKCICstudy Email:  uk-cic@immunology.org</p><p>英国冠状病毒免疫联盟汇集了英国19个优秀的免疫学中心，研究免疫系统如何与SARS-CoV-2相互作用，帮助我们改善患者护理，并开发针对新冠肺炎的更好的诊断、治疗和疫苗。它由英国研究与创新(UKRI)和国家健康研究所(NIHR)联合资助，并得到英国免疫学会的支持。网址：www.uk-cic.org/twitter：@UKCICStudy电子邮件：uk-cic@Immunology.org</p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://www.uk-cic.org/news/cellular-immunity-sars-cov-2-found-six-months-non-hospitalised-individuals">https://www.uk-cic.org/news/cellular-immunity-sars-cov-2-found-six-months-non-hospitalised-individuals</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/sars/">#sars</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/immunity/">#immunity</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/研究/">#研究</a></button></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/美国/">#美国</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/谷歌/">#谷歌</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/linux/">#linux</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/程序/">#程序</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy; 2020 diglog.com </div></div></body></html>